Your browser doesn't support javascript.
loading
Toxicological evaluation of 5-methoxy-2-aminoindane (MEAI): Binge mitigating agent in development.
Shimshoni, Jakob A; Winkler, Ilan; Edery, Nir; Golan, Ezekiel; van Wettum, René; Nutt, David.
Affiliation
  • Shimshoni JA; Kimron Veterinary Institute, Department of Toxicology, Bet Dagan, Israel. Electronic address: jakobshimshoni@gmail.com.
  • Winkler I; Pharmaseed Ltd, Ness Ziona, Israel.
  • Edery N; Kimron Veterinary Institute, Department of Pathology, Bet Dagan, Israel.
  • Golan E; BSC BV Company, Veemarkt 61, Amsterdam, The Netherland.
  • van Wettum R; BSC BV Company, Veemarkt 61, Amsterdam, The Netherland.
  • Nutt D; Imperial College London, Neuropsychopharmacology Unit, London, UK.
Toxicol Appl Pharmacol ; 319: 59-68, 2017 03 15.
Article in En | MEDLINE | ID: mdl-28167221

Full text: 1 Database: MEDLINE Main subject: Body Weight / Drug Discovery / Binge Drinking / Indans Language: En Journal: Toxicol Appl Pharmacol Year: 2017 Type: Article

Full text: 1 Database: MEDLINE Main subject: Body Weight / Drug Discovery / Binge Drinking / Indans Language: En Journal: Toxicol Appl Pharmacol Year: 2017 Type: Article